Microvessel count predicts metastasis and prognosis in patients with gastric cancer
Araya M, Terashima M, Takagane A et al. Microvessel count predicts metastasis and prognosis in patients with gastric cancer. J Surg Oncol, 1997, 65:232
Quantitation of sinusoid-like vessels in hepatocellular carcinoma: Its clinical and prognostic significance
Tanigawa N, Lu C, Mitsui T et al. Quantitation of sinusoid-like vessels in hepatocellular carcinoma: its clinical and prognostic significance. Hepatology, 1997, 26:1216
Microvessel density of hepatocellular carcinoma: Its relationship with prognosis
Sun H C, Tang Z Y, Li X M et al. Microvessel density of hepatocellular carcinoma: its relationship with prognosis. J Cancer Res Clin Oncol, 1999, 125:419
Co-expression of Bcl-2 protein and vascular endothelial growth factor in hepatocellular carcinomas treated by chemoembolization
Kobayashi N, Ishii M, Ueno Y et al. Co-expression of Bcl-2 protein and vascular endothelial growth factor in hepatocellular carcinomas treated by chemoembolization. Liver, 1999, 19:25
Insulin-like growth factor i induced by hypoxia may contribute to angiogenesis of hepatocellular carcinoma
Kim KM, Bae SK, Lee OH et al. Insulin-like growth factor I induced by hypoxia may contribute to angiogenesis of hepatocellular carcinoma. Cancer Res, 1998, 58: 348
Role of tumor necrosis factor-alpha in the pathophysiologic alterations after hepatic ischemia/reperfusion injury in the rat
Colletti L M, Remick D G, Burtch G D et al. Role of tumor necrosis factor-alpha in the pathophysiologic alterations after hepatic ischemia/reperfusion injury in the rat. J Clin Invest, 1990, 85:1936
Antivascular endothelial growth factor receptor (fetal liver kinase 1) monoclonal antibody inhibits tumor angiogenesis and growth of several mouse and human tumors
Prewett M, Huber J, Li Y et al. Antivascular endothelial growth factor receptor (fetal liver kinase 1) monoclonal antibody inhibits tumor angiogenesis and growth of several mouse and human tumors. Cancer Res, 1999, 59:5209
Continuous administration of angiostatin inhibits accelerated growth of colorectal liver metastasis after partial hepatectomy
Drixler T A, Rinkes I H, Ritchie E D et al. Continuous administration of angiostatin inhibits accelerated growth of colorectal liver metastasis after partial hepatectomy. Cancer Res, 2000, 60:1761